Patients with autoimmune lymphoproliferative syndrome (ALPS), who bear mutations affecting FasL or caspase-10, show increased risk of Hodgkin (HL) and non-Hodgkin lymphoma (NHL), highlighting the importance of the extrinsic apoptosis pathway [37]. This evidence concerns the gene CASP10 and autoimmune lymphoproliferative syndrome.